Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

More Calls for Transparency As CVS Hit With 340B Suits No Photo Available

A series of complaints lodged against health giant CVS may be a bellwether for more scrutiny to come against healthcare middlemen.

New Suits Target DOJ Release, Loan Rule And More No Photo Available

Law360 Healthcare Authority looks at new suits filed over the past week, including a $50 million suit over the U.S. Justice Department... (more story)

Meet The Attys For Health Orgs. Fighting Ed. Dept. Loan Caps No Photo Available

A group of healthcare organizations has tapped a new law firm founded by a former Biden administration attorney to challenge a U.S. De... (more story)